PRAME

gene product
CT130, MAPE
This gene encodes an antigen that is preferentially expressed in human melanomas and that is recognized by cytolytic T lymphocytes. It is not expressed in normal tissues, except testis. The encoded protein acts as a repressor of retinoic acid receptor, and likely confers a growth advantage to cancer cells via this function. Alternative splicing results in multiple transcript variants. [provided by RefSeq, Apr 2014]
More gene data

Featured antibodies

Antibodies

 

Filters

Application

Antibodypedia Validation Initiative

Validation method

Reference

Provider

Host

Reactivity

Antibody type

Conjugate

Antibody

  or   Clear
Enhanced validation
Enhanced validation
Supportive data in Antibodypedia
Data presented on provider website
Data in Antibodypedia (inconclusive)
Validated within AVI
Eligible for validation within AVI
248 antibodies from 28 providers.

Antibody properties

General

Applications

or Cancel
AntibodyRefsTypeWBELICCIPIHCFC
antibodies-online
88 antibodies
Atlas Antibodies
3 antibodies
Aviva Systems Biology
3 antibodies
Novus Biologicals
8 antibodies
Abnova Corporation
6 antibodies
Biorbyt
13 antibodies
Cell Signaling Technology, Inc
2 antibodies
Abgent
1 antibody
Invitrogen Antibodies
5 antibodies
LifeSpan BioSciences, Inc.
42 antibodies
Bioworld Technology, Inc
1 antibody
NovoPro Bioscience Inc.
1 antibody
OriGene
6 antibodies
Acris Antibodies GmbH
5 antibodies
ReliaTech GmbH
2 antibodies
ProSci
1 antibody
St John's Laboratory
2 antibodies
Proteintech Group
1 antibody
Creative Diagnostics
2 antibodies
RabMAbs
1 antibody
GeneTex
5 antibodies
MyBioSource
3 antibodies
United States Biological
27 antibodies
Creative Biolabs
3 antibodies
Affinity Biosciences
1 antibody
Abbexa
3 antibodies
Sigma-Aldrich
1 antibody